Thomas J. Herzfeld Advisors Inc. Buys 4,500 Shares of iShares NASDAQ Biotechnology Index (IBB)

Thomas J. Herzfeld Advisors Inc. grew its stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 750.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,100 shares of the financial services provider’s stock after buying an additional 4,500 shares during the quarter. Thomas J. Herzfeld Advisors Inc.’s holdings in iShares NASDAQ Biotechnology Index were worth $545,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Tarbox Family Office Inc. grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock worth $113,000 after purchasing an additional 706 shares during the last quarter. Bollard Group LLC grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock worth $126,000 after purchasing an additional 784 shares during the last quarter. Aua Capital Management LLC grew its stake in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Aua Capital Management LLC now owns 1,200 shares of the financial services provider’s stock worth $128,000 after purchasing an additional 800 shares during the last quarter. FNY Partners Fund LP bought a new stake in shares of iShares NASDAQ Biotechnology Index in the third quarter worth about $133,000. Finally, Edge Wealth Management LLC grew its stake in shares of iShares NASDAQ Biotechnology Index by 381.8% in the fourth quarter. Edge Wealth Management LLC now owns 1,272 shares of the financial services provider’s stock worth $136,000 after purchasing an additional 1,008 shares during the last quarter. 61.47% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Shares of iShares NASDAQ Biotechnology Index (IBB) opened at $112.74 on Friday. iShares NASDAQ Biotechnology Index has a 12 month low of $94.20 and a 12 month high of $119.30.

COPYRIGHT VIOLATION WARNING: This report was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3275510/thomas-j-herzfeld-advisors-inc-buys-4500-shares-of-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

ExxonMobil  Forecasted to Post Q1 2018 Earnings of $1.16 Per Share
ExxonMobil Forecasted to Post Q1 2018 Earnings of $1.16 Per Share
Assicurazioni Generali  Given a €14.50 Price Target by Goldman Sachs Analysts
Assicurazioni Generali Given a €14.50 Price Target by Goldman Sachs Analysts
Schneider Electric  Given a €88.00 Price Target by Societe Generale Analysts
Schneider Electric Given a €88.00 Price Target by Societe Generale Analysts
Essilor International  Given a €104.40 Price Target at JPMorgan Chase
Essilor International Given a €104.40 Price Target at JPMorgan Chase
Berenberg Bank Analysts Give Danone  a €72.50 Price Target
Berenberg Bank Analysts Give Danone a €72.50 Price Target
Zooplus  Given a €140.00 Price Target by Kepler Capital Markets Analysts
Zooplus Given a €140.00 Price Target by Kepler Capital Markets Analysts


© 2006-2018 Ticker Report. Google+.